The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density ...
Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Patients with osteoporosis may benefit from treatment initiation with an anabolic agent followed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results